DENVER--(BUSINESS WIRE)--VieCure today announced a new collaboration with Labcorp to provide clinicians greater access to precision oncology decision support. This strategic collaboration will support ...

This understanding is driving a shift from isolated tests to comprehensive diagnostic panels; carefully structured groups of ...

Illumina, Inc. (NASDAQ: ILMN) today announced that reimbursement has been granted for its FDA-approved in vitro diagnostic ...

The advent of multiomic approaches has significantly improved early cancer detection by integrating diverse molecular data to gain a more complete understanding of disease processes. While advances in ...

Making is Fueling Strong Growth in Pan-Genomic and Multi-Gene Panel Testing, Supported by Expanding NGS Access, Advanced ...

TAIPEI, Nov. 28, 2025 /PRNewswire/ -- Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI). Multi-Cancer Early Detection (MCED) has ...

To evaluate the effectiveness of a comprehensive screening program for individuals with genetic predisposition to cancer, focusing on early detection and improved treatment outcomes through systematic ...

Gone are the days when oncologists reacted to a cancer diagnosis by using the few drugs we had and hoping for the best. We have evolved from being reactive to proactive, primarily due to advances in ...